TR201007110A2 - Sinerjik etki gösteren kombinasyonlar - Google Patents

Sinerjik etki gösteren kombinasyonlar

Info

Publication number
TR201007110A2
TR201007110A2 TR2010/07110A TR201007110A TR201007110A2 TR 201007110 A2 TR201007110 A2 TR 201007110A2 TR 2010/07110 A TR2010/07110 A TR 2010/07110A TR 201007110 A TR201007110 A TR 201007110A TR 201007110 A2 TR201007110 A2 TR 201007110A2
Authority
TR
Turkey
Prior art keywords
combinations
synergistic effects
memantine
alzheimer
directed
Prior art date
Application number
TR2010/07110A
Other languages
English (en)
Turkish (tr)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2010/07110A priority Critical patent/TR201007110A2/xx
Priority to PCT/TR2011/000190 priority patent/WO2012026902A1/en
Publication of TR201007110A2 publication Critical patent/TR201007110A2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TR2010/07110A 2010-08-25 2010-08-25 Sinerjik etki gösteren kombinasyonlar TR201007110A2 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2010/07110A TR201007110A2 (tr) 2010-08-25 2010-08-25 Sinerjik etki gösteren kombinasyonlar
PCT/TR2011/000190 WO2012026902A1 (en) 2010-08-25 2011-08-19 Combinations comprising donepezil, memantine and gingko biloba extract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2010/07110A TR201007110A2 (tr) 2010-08-25 2010-08-25 Sinerjik etki gösteren kombinasyonlar

Publications (1)

Publication Number Publication Date
TR201007110A2 true TR201007110A2 (tr) 2012-03-21

Family

ID=44801125

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2010/07110A TR201007110A2 (tr) 2010-08-25 2010-08-25 Sinerjik etki gösteren kombinasyonlar

Country Status (2)

Country Link
TR (1) TR201007110A2 (xx)
WO (1) WO2012026902A1 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014007775A1 (en) * 2012-07-02 2014-01-09 Mahmut Bilgic A novel formulation having fast dissolution
WO2014035355A1 (en) * 2012-08-31 2014-03-06 Mahmut Bilgic Pharmaceutical combination comprising idebenone and memantine
WO2014055047A1 (en) * 2012-08-31 2014-04-10 Mahmut Bilgic Combination of idebenone and donezepil
WO2015120013A1 (en) 2014-02-04 2015-08-13 Forest Laboratories Holdings Limited Donepezil compositions and method of treating alzheimer's disease
KR101938872B1 (ko) * 2016-09-30 2019-01-16 주식회사 바이오파마티스 도네페질 또는 그의 약학적으로 허용 가능한 염 및 메만틴 또는 그의 약학적으로 허용 가능한 염을 함유하는 치매 및 인지기능 장애 예방 또는 치료용 약학 조성물 및 이의 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI95572C (fi) 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
MXPA04011762A (es) 2002-05-31 2005-03-31 Lundbeck & Co As H Una combinacion de antagonista de nmda e inhibidores de acetilcolinesterasa para el tratamiento de la enfermedad de alzheimer.
DK2332408T3 (da) * 2005-02-17 2013-12-02 Biogen Idec Inc Behandling af neurologiske sygdomme

Also Published As

Publication number Publication date
WO2012026902A1 (en) 2012-03-01

Similar Documents

Publication Publication Date Title
BR112015020466A8 (pt) inibidores de cdc7, seus usos, e composição farmacêutica
EP4272834A3 (en) Therapeutic use of mitochondria and combined mitochondrial agents
TN2016000238A1 (en) Tricyclic compounds as anticancer agents.
MX2020010535A (es) Inhibidor de ezh2 para usarse en el tratamiento de sarcoma epiteloide.
BR112015027288A8 (pt) uso de uma dose de imunossupressor, composição de nanocarreadores sintéticos tolerogênicos e kit
SMT201600182B (it) Ligandi sigma per l'uso nella prevenzione e/o nel trattamento del dolore post-operatorio
CL2013003577A1 (es) Uso de una composicion farmaceutica que comprende panobinostat y ruxolitinib en la prevencion y/o tratamiento de neoplasias mieloproliferativas.
CL2008003593A1 (es) Compuestos derivados de isoxazolo-piridazina; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de trastornos cognitivos como el alzheimer
UA109650C2 (xx) Біс-арилзв'язані арилтриазолони та їх застосування
CL2011002548A1 (es) Compuestos derivados de resolviina; composicion farmaceutica; uso de la composicion; kit farmaceutico; combinacion farmaceutica; uso de los compuestos en el tratamiento y/o prevencion de una condicion oftalmica.
BR112015006055A2 (pt) composições e métodos para o tratamento e prevenção de lesão tecidual e doença
BR112015022545A2 (pt) compostos de pirazolo e os usos disso
BR112015010663A2 (pt) formas de dosagem de ruxolitinib de liberação sustentada
MX2016002238A (es) Alcoholes de alquilino y metodos de uso.
BR112015015898A8 (pt) composição farmacêutica de solução sólida, e, uso de uma composição farmacêutica
DOP2013000007A (es) Pirimidinadas y triazinas condensadas y su uso
MX2016002241A (es) Alcoholes de alquinilo y metodos de uso.
CL2009000119A1 (es) Compuestos derivados de amino-bencimidazoles sustituidos; composicion farmaceutica; y su uso en el tratamiento del alzheimer.
BR112014003109A2 (pt) variantes de plasminogênio e plasmina
TR201903840T4 (tr) İnsan tamamlayıcı C5'e bağlanan polipeptitler.
BR112016004358A8 (pt) combinação farmacêutica de um inibidor de alk e um inibidor de cdk para tratamento de doenças proliferativas de célula, composição farmacêutica, seus usos, e kit
TR201007110A2 (tr) Sinerjik etki gösteren kombinasyonlar
CL2012001940A1 (es) Composiciones que comprenden extractos de andrographis paniculata combinados con extractos de ginkgo biloba complejados con fosfolípidos; y su uso en la preparación de un medicamento para el tratamiento de alzheimer y esclerosis múltiple.
CL2015000039A1 (es) Derivados estra-1,3,5(10),16-tetraeno-3-sustituidos, preparaciones farmacéuticas que los comprenden y su uso en la preparación de medicamentos para tratar la endometriosis.
CL2014003325A1 (es) Compuestos derivados de difluoro-hexahidro-ciclopentaoxacinilos y difluoro-hexahidro-benzooxacinilos, inhibidores de bace 1; composicion farmaceutica; y su uso en el tratamiento de enfermedades con niveles elevados de beta-amiloide, tal como la enfermedad de alzheimer